Mads Dalsgaard is Senior Vice President and Global Head of Experimental Medicine and Clinical Development in Lundbeck. An MD by training with experience from neurology and holds a DMSc in neuroscience as well as an MBA from IMD in Switzerland. Within Lundbeck, Mads Dalsgaard is responsible for global Clinical Development from first-in-man to registration and beyond to phase IV. He is a strong advocate of leveraging innovative and technological tools to support and facilitate clinical development, both on scientific and operational aspects such as around digitalization, data science, biomarkers and bioinformatics, to both secure translational planning and optimal development planning and for the benefit of all stakeholders including patients and caregivers. He is furthermore passionate around precompetitive collaboration across institutions and companies to drive R&D productivity among others through data sharing.